Management of Iron Deficiency Identified on CBC
Start with oral iron supplementation (30-100 mg elemental iron daily) combined with vitamin C for most patients, but move directly to intravenous iron if oral iron is not tolerated, fails to improve ferritin levels after a trial period, or if the patient has conditions affecting iron absorption. 1
Initial Diagnostic Confirmation
When CBC suggests iron deficiency (typically microcytic anemia with low hemoglobin), confirm with:
- Serum ferritin (most important single test)
- Transferrin saturation
- Consider reticulocyte hemoglobin equivalent (RET-He <30.7 pg supports iron deficiency diagnosis) 2
Important caveat: In patients with inflammatory conditions (IBD, CKD, heart failure), ferritin can be falsely elevated. In these cases, ferritin <100 μg/L may still indicate iron deficiency, and transferrin saturation becomes more valuable 1, 3.
Identify the Underlying Cause
Before or concurrent with treatment, investigate the source:
- Premenopausal women: Assess menstrual blood loss and gynecologic causes
- Men and postmenopausal women: Require GI evaluation (bidirectional endoscopy) to exclude malignancy and bleeding sources 1
- All patients: Check for celiac disease, H. pylori infection, dietary insufficiency
- Review medications (NSAIDs, anticoagulants, antiplatelets)
Treatment Algorithm
First-Line: Oral Iron Supplementation
Dosing strategy:
- 30-100 mg elemental iron daily 1, 4
- Add vitamin C to enhance absorption 1
- Alternate-day dosing may improve tolerance with similar absorption 1
Monitor response: Recheck CBC and ferritin at 8-10 weeks 5
When to Use Intravenous Iron Instead
Move to IV iron if: 1
- Patient cannot tolerate oral iron (GI side effects are common)
- Ferritin fails to improve after oral iron trial
- Conditions where oral absorption is compromised:
- Post-bariatric surgery (especially procedures disrupting duodenal absorption) 1
- Active inflammatory bowel disease with inflammation 1
- Chronic kidney disease on dialysis 3
- Chronic heart failure (oral iron poorly absorbed due to gut edema and shows no prognostic benefit) 3
- Celiac disease with poor adherence to gluten-free diet 1
IV iron formulation choice:
- Prefer formulations allowing complete replacement in 1-2 infusions (e.g., ferric carboxymaltose) 1
- All IV iron formulations have similar safety profiles; true anaphylaxis is very rare 1
- Most reactions are complement activation-related pseudo-allergy (infusion reactions), not true allergies 1
Special Population Considerations
Inflammatory Bowel Disease
- Determine if deficiency is from inadequate intake/absorption vs. blood loss 1
- Treat active inflammation to enhance iron absorption 1
- Use IV iron if active inflammation with compromised absorption 1
- Oral iron should not exceed 100 mg elemental iron daily 3
Chronic Kidney Disease
- Different ferritin thresholds: absolute deficiency defined as transferrin saturation ≤20% with ferritin ≤100 μg/L (predialysis/peritoneal dialysis) or ≤200 μg/L (hemodialysis) 3
- IV iron required if oral fails or patient on dialysis 3
- Coordinate with nephrology team
Chronic Heart Failure
- Screen with ferritin and transferrin saturation 3
- Use IV iron preferentially - has demonstrated prognostic benefit in meta-analyses 3
- Avoid oral iron (poorly absorbed, frequent side effects, no proven benefit) 3
Post-Bariatric Surgery
- IV iron is preferred due to disrupted duodenal absorption 1
Critical Pitfalls to Avoid
- Don't miss GI malignancy: Men and postmenopausal women with confirmed iron deficiency need endoscopic evaluation unless there's an obvious alternative cause
- Don't rely solely on hemoglobin: Iron deficiency without anemia still causes significant symptoms (fatigue, reduced exercise tolerance, cognitive impairment) and warrants treatment 6, 5
- Don't misinterpret ferritin in inflammation: Check C-reactive protein; elevated ferritin may mask iron deficiency in inflammatory states 1, 3
- Don't continue ineffective oral iron indefinitely: If no response after 8-10 weeks, switch to IV iron 1
- Blood transfusion is NOT appropriate treatment for iron deficiency anemia except in hemodynamically unstable patients 6, 4